In a bid to boost export capability of Indian pharmaceutical companies, the Export-Import Bank of India (Exim Bank) has decided to expand the scope of its finance to them for extended repayment periods.
Despite having potential to increase their share in global exports, many Indian pharmaceutical companies suffer due to their inability to meet the stringent compliance norms of European countries and the USA. Read more
